摘要
目的探讨后肾始基腺瘤(metanephricadenoma,MA)的临床及病理特点。方法对10例MA患者的临床资料进行回顾性分析。本组10例,男4例,女6例。年龄33~65岁,平均45岁。表现为肉眼血尿4例,腰痛2例,查体发现4例。B超检查诊断为肾实性占位9例,肾囊肿1例。CT检查示肾实性占位9例,囊实性1例,10例均有不同程度强化,肿瘤直径2.5~8.0cm,平均4.5cm,诊断为肾癌9例,囊性肾癌1例。行根治性肾切除术9例,肾部分切除术1例。结果病理检查:肿瘤细胞排列成密集的小管状或腺样结构,部分可见乳头状或肾小球样结构,肿瘤与肾组织分界清楚。病理诊断为MA4例,低度恶性MA2例,MA伴恶性成分4例(高分化腺癌2例,嫌色细胞癌1例,高分化乳头状腺癌1例)。7例随访10~34个月,平均22个月,未见复发及转移。结论MA是一种罕见的肾脏良性上皮源性肿瘤,部分可含有恶性成分,少数为恶性,容易误诊为肾癌。保留肾单位手术和根治性肾切除术为主要治疗方法。因其生物学行为不确定,需长期随访。
Objective To explore the clinical and histopathological features of metanephric adenoma (MA). Methods Clinical and pathological data of 10 cases of MA were analyzed retrospectively. There were 4 males and 6 females, aged from 33 to 65 years, with an average of 45 years. 2 patients had flank pain, 4 patients had gross hematuria, and 4 patients were found by physical examination. The average diameter of tumor was 4.5 cm (2.5 - 8.0 cm). All patients were diagnosed as renal tumor by CT scan. 9 patients underwent radical nephrectomy and 1 patient underwent partial nephrectomy. Results Pathological examination found that the tumors are composed of densely packed small uniform cells with regular nuclei that formed a tubular or adenoid pattern. Mitotic figures were absent or rare. 4 patients were diagnosed as MA, 2 cases were diagnosed as low-grade malignant MA, and 4 cases were diagnosed as MA with malignant component (2 cases of adenoearcinoma, 1 case of chromophobe cell carcinoma, and 1 case of well differenti- ated papillary adenocarcinoma) , 7 cases were followed up for 22 months ( 10 to 34 months) without recurrence or metastasis. Conclusions MA is very rare benign renal tumor originating from epithelium,and a few are malignant, and some may contain malignant ingredients. Nephron-sparing surgery and radical nephrectomy are eligible for the treatment of MA . Considering the uncertainty of the biological behavior and cellular origin of MA, a long-term follow-up is necessary.
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2012年第1期47-50,共4页
Chinese Journal of Urology
关键词
肾脏
后肾始基腺瘤
治疗
病理
Kidney
Metanephric adenoma
Treatment
Pathology